CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
BERIL-1: A phase II, placebo-controlled study of buparlisib (BKM120) plus paclitaxel in patients with platinum-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).
Author
Andrey Karpenko
Arunava Chakravartty
+18Â more
Arunee Dechaphunkul
Cristian Massacesi
Debarshi Dey
Denis Soulieres
Eva Remenar
Jin-Ching Lin
Jozsef Erfán
Laszlo Tamas
Laura Anna Kiss
Lisa F. Licitra
Paola Aimone
Rajnish Vasant Nagarkar
Ricard Mesia
Sabine Turri
Sandrine J. Faivre
Shau-Hsuan Li
Sung-Bae Kim
Ulrich Keilholz
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref